How Does Invasive Breast Cancer Oncotype Dx Recurrence Score on Core Needle Biopsies Influence Neoadjuvant Treatment Decision? A Descriptive Study

BACKGROUND: Oncotype Dx (ODx) is a genomic assay which estimates the risk of distant recurrence and predicts adjuvant chemotherapy benefit in early stage breast cancer patients. Most ODx data is derived from excisional specimens. AIM: We assess the utility of ODx on core needle biopsies (CNB) and me...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Gahie, Singh, Kamaljeet, Lopresti, Mary L., Ouseph, Madhu M., Wang, Li Juan, Wang, Yihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552406/
https://www.ncbi.nlm.nih.gov/pubmed/34696631
http://dx.doi.org/10.1177/15330338211035037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552406/
https://www.ncbi.nlm.nih.gov/pubmed/34696631
http://dx.doi.org/10.1177/15330338211035037

Ejemplares similares